PARP1 and cancer: In recent years, there is a new generation of PARP inhibitors available in cancer chemotherapy (Coleman et al., 2015; Gunderson & Moore, 2015; Jones et al., 2015; Thomas et al., 2007), which are much more potent than the classical ones.